|
Index of reports
> Cases resulting in disability (12)
> Cases with Dyspnoea (3)
Below is the selection of adverse event reports related to Thalomid (Thalidomide) that includes cases resulting in disability where reactions include dyspnoea.
Adverse event in 58 year old male receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-03-07
Patient: 58 year old male
Adverse reactions / side effects: Spinal Cord Compression, Soft Tissue Disorder, Confusional State, Dyspnoea, Mass, Mental Status Changes, Multiple Myeloma, Fall, Paraesthesia, Disease Progression, Paraplegia, NO Therapeutic Response, Metastases TO Central Nervous System, Spinal Column Stenosis
Adverse event resulted in: death, hospitalization, disablity
Suspect drug(s):
Thalomid (Thalidomide)
Other drugs received by patient: Dexamethasone TAB; Vincristine; Adriamycin PFS
Adverse event in 58 year old male receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-02-14
Patient: 58 year old male
Adverse reactions / side effects: Spinal Cord Compression, Confusional State, Refusal of Treatment by Patient, Dyspnoea, Abasia, Malignant Neoplasm Progression, Mental Status Changes, Hypoaesthesia, Multiple Myeloma, Fall, Paraesthesia, Lumbar Spinal Stenosis, Meningeal Neoplasm, Metastases TO Central Nervous System
Adverse event resulted in: death, hospitalization, disablity
Suspect drug(s):
Thalomid (Thalidomide)
Other drugs received by patient: Dexamethasone TAB; Radiatio0n Therapy; Vincristine; Adriamycin PFS
Adverse event in 74 year old male receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-02-02
Patient: 74 year old male
Adverse reactions / side effects: Neuropathy, Blood Urea Increased, Dyspnoea, Muscle Atrophy, Pneumonia, Atrial Fibrillation, Haemoglobin Decreased, Protein Urine, Drug Toxicity, Fatigue, Diarrhoea, Alopecia, Gait Disturbance
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Decadron
Dosage: 200 mg, 4 in 1 d, oral
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2005-01-03
End date: 2006-05-01
Thalomid
Dosage: 200 mg, 4 in 1 d, oral
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2005-01-03
End date: 2006-05-01
Other drugs received by patient: Baldex; Procrit; Diltiazem; Pravachol; Prilosec; Toprol-XL; Coumadin
|
